Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1986 Jan;55(1):58–66. doi: 10.1136/hrt.55.1.58

Haemostatic function in myocardial infarction.

A Hamsten, M Blombäck, B Wiman, J Svensson, A Szamosi, U de Faire, L Mettinger
PMCID: PMC1232069  PMID: 3947483

Abstract

Coagulation factor VIII, von Willebrand factor, antithrombin, fibrinogen, plasminogen activator capacity, and inhibitors of fibrinolysis, including a recently discovered fast inhibitor of tissue plasminogen activator, were measured three to six months after myocardial infarction in 116 male and 32 female patients aged less than 45 and in 136 age and sex matched random controls. Plasma concentrations of fibrinogen and the fast inhibitor of tissue plasminogen activator were raised in male patients (with or without correction for orosomucoid levels, blood group distribution, tobacco and alcohol consumption, and weight/height index) and plasminogen activator capacity was reduced. In female patients the concentrations of factor VIII, von Willebrand factor, the fast inhibitor of tissue plasminogen activator, alpha 2-antiplasmin, and C1 inhibitor were significantly increased. The increase in factor VIII concentrations depended strongly on a persisting inflammatory response. Multivariate analysis indicated that a combination of fibrinogen and tissue plasminogen activator inhibitor concentrations gave the best independent discrimination between male patients and controls. For female patients the best combination was von Willebrand factor and tissue plasminogen activator inhibitor. Male patients with multiple vessel atheromatosis at coronary angiography had higher fibrinogen concentrations than those with atheromatosis of a single vessel. Atheromatosis was defined as sharp-edged, plaque-like, or irregular indentations, often multiple, into the vessel lumen without features suggesting fibromuscular hyperplasia.

Full text

PDF
59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard U., Lie M., Odegård O. R. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res. 1977 Oct;11(4):549–553. doi: 10.1016/0049-3848(77)90208-0. [DOI] [PubMed] [Google Scholar]
  2. Austen W. G., Edwards J. E., Frye R. L., Gensini G. G., Gott V. L., Griffith L. S., McGoon D. C., Murphy M. L., Roe B. B. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975 Apr;51(4 Suppl):5–40. doi: 10.1161/01.cir.51.4.5. [DOI] [PubMed] [Google Scholar]
  3. Baker I. A., Eastham R., Elwood P. C., Etherington M., O'Brien J. R., Sweetnam P. M. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J. 1982 May;47(5):490–494. doi: 10.1136/hrt.47.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  5. Ciraulo D. A., Bresnahan G. F., Frankel P. S., Isely P. E., Zimmerman W. R., Chesne R. B. Transmural myocardial infarction with normal coronary angiograms and with single vessel coronary obstruction. Clinical-angiographic features and five-year follow-up. Chest. 1983 Feb;83(2):196–202. doi: 10.1378/chest.83.2.196. [DOI] [PubMed] [Google Scholar]
  6. Denson K. W. The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res. 1977 Jan;10(1):107–119. doi: 10.1016/0049-3848(77)90084-6. [DOI] [PubMed] [Google Scholar]
  7. Efendić S., Wajngot A., Cerasi E., Luft R. Insulin release, insulin sensitivity, and glucose intolerance. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7425–7429. doi: 10.1073/pnas.77.12.7425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Franzén J., Nilsson B., Johansson B. W., Nilsson I. M. Fibrinolytic activity in men with acute myocardial infarction before 60 years of age. Acta Med Scand. 1983;214(5):339–344. doi: 10.1111/j.0954-6820.1983.tb08606.x. [DOI] [PubMed] [Google Scholar]
  9. Gallimore M. J., Friberger P. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Thromb Res. 1982 Feb 1;25(3):293–298. [PubMed] [Google Scholar]
  10. HUGGETT A. S., NIXON D. A. Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet. 1957 Aug 24;273(6991):368–370. doi: 10.1016/s0140-6736(57)92595-3. [DOI] [PubMed] [Google Scholar]
  11. Korsan-Bengtsen K., Wilhelmsen L., Elmfeldt D., Tibblin G. Blood coagulation and fibrinolysis in man after myocardial infarction compared with a representative population sample. Atherosclerosis. 1972 Jul-Aug;16(1):83–88. doi: 10.1016/0021-9150(72)90010-x. [DOI] [PubMed] [Google Scholar]
  12. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  13. Lowe G. D., Drummond M. M., Lorimer A. R., Hutton I., Forbes C. D., Prentice C. R., Barbenel J. C. Relation between extent of coronary artery disease and blood viscosity. Br Med J. 1980 Mar 8;280(6215):673–674. doi: 10.1136/bmj.280.6215.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  16. Nicolaides A. N., Horbourne T., Bowers R., Kidner P. H., Besterman E. M. Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina. Lancet. 1977 Nov 5;2(8045):943–945. doi: 10.1016/s0140-6736(77)90886-8. [DOI] [PubMed] [Google Scholar]
  17. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  18. Norén I., Ramström G., Wallén P. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma. Haemostasis. 1975;4(2):110–124. doi: 10.1159/000214094. [DOI] [PubMed] [Google Scholar]
  19. O'Brien J. R., Etherington M. D., Jamieson S., Lawford P., Lincoln S. V., Alkjaersig N. J. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb Diath Haemorrh. 1975 Nov 15;34(2):483–497. [PubMed] [Google Scholar]
  20. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Savidge G., Blombäck M., Blombäck B. Studies of F VIII procoagulant activity in plasma and concentrates using a semi-automated thrombin generation assay. Thromb Res. 1979;16(3-4):355–365. doi: 10.1016/0049-3848(79)90083-5. [DOI] [PubMed] [Google Scholar]
  22. Sharma S. C., Seth H. N. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction. Br Heart J. 1978 May;40(5):526–529. doi: 10.1136/hrt.40.5.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sixma J. J. The prethrombotic state. Br J Haematol. 1980 Dec;46(4):515–522. doi: 10.1111/j.1365-2141.1980.tb06007.x. [DOI] [PubMed] [Google Scholar]
  24. Stormorken H., Erikssen J. Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle-aged men. Thromb Haemost. 1977 Dec 15;38(4):874–878. [PubMed] [Google Scholar]
  25. Teger-Nilsson A. C., Friberger P., Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977 Sep;37(5):403–409. [PubMed] [Google Scholar]
  26. VERMYLEN C., DE VREKER R. A., VERSTRAETE M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chim Acta. 1963 May;8:418–424. doi: 10.1016/0009-8981(63)90080-9. [DOI] [PubMed] [Google Scholar]
  27. Vanhaecke J., Piessens J., Willems J. L., De Geest H. Coronary arterial lesions in young men who survived a first myocardial infarction: clinical and electrocardiographic predictors of multivessel disease. Am J Cardiol. 1981 Apr;47(4):810–814. doi: 10.1016/0002-9149(81)90178-8. [DOI] [PubMed] [Google Scholar]
  28. Warren S. E., Thompson S. I., Vieweg W. V. Historic and angiographic features of young adults surviving myocardial infarction. Chest. 1979 Jun;75(6):667–670. doi: 10.1378/chest.75.6.667. [DOI] [PubMed] [Google Scholar]
  29. Weiss H. J., Baumgartner H. R., Tschopp T. B., Turitto V. T., Cohen D. Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood. 1978 Feb;51(2):267–279. [PubMed] [Google Scholar]
  30. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  31. Wiman B., Chmielewska J. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance. Scand J Clin Lab Invest Suppl. 1985;177:43–47. [PubMed] [Google Scholar]
  32. Wiman B., Nilsson T. A new simple method for determination of C1-esterase inhibitor activity in plasma. Clin Chim Acta. 1983 Mar 14;128(2-3):359–366. doi: 10.1016/0009-8981(83)90335-2. [DOI] [PubMed] [Google Scholar]
  33. Wolinsky H. A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res. 1980 Sep;47(3):301–311. doi: 10.1161/01.res.47.3.301. [DOI] [PubMed] [Google Scholar]
  34. Yue R. H., Gertler M. M., Starr T., Koutrouby R. Alteration of plasma antithrombin III levels in ischemic heart disease. Thromb Haemost. 1976 Jun 30;35(3):598–606. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES